Elizabethkingia meningoseptica Infection in COVID-19 Patients

Mas Chaponda1, Adila Shaukat1, Mohammad Wajeh Dulli2

  • 1Infectious Diseases Department, Hamad Medical Corporation, Doha, QAT.

Cureus
|November 21, 2022
PubMed

Insights

Coinfections with Elizabethkingia meningoseptica (EM) are emerging in severe COVID-19 patients. These superinfections show high antimicrobial resistance, leading to poor patient outcomes.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • The COVID-19 pandemic has seen an increase in bacterial and fungal coinfections.
  • Antimicrobial resistance is a growing concern in managing severe COVID-19 cases.

Observation:

  • Three cases of Elizabethkingia meningoseptica (EM) superinfections in COVID-19 patients are presented.
  • These patients were critically ill, intubated, and had central venous catheters.
  • They received extensive prior treatment including antibiotics, antivirals, and dexamethasone.

Findings:

  • Elizabethkingia meningoseptica isolates demonstrated resistance to most tested antibiotics.
  • All three patients experienced poor treatment outcomes.

Implications:

  • This highlights the need for vigilance regarding unusual bacterial superinfections in severe COVID-19.
  • Emergence of multidrug-resistant EM poses a significant challenge in critical care settings.
  • Further research into optimal management strategies for EM superinfections in immunocompromised patients is warranted.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
424
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
353
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
425
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
22
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
11
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
21